TFR Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
TFR Capital's BMY Position: Q2 2026 in Review
TFR Capital increased its Bristol-Myers Squibb (BMY) stake by 0.22% in Q2 2026, buying an estimated $574 and bringing the position to 4,481 shares worth $258K. The position accounts for 0.07% of the portfolio, ranked #154.
TFR Capital first reported a position in BMY in Q2 2025 and has held it in 4 quarters since. The position peaked at $271K in Q1 2026. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- TFR Capital held 4,481 shares of Bristol-Myers Squibb worth $258K as of Q2 2026.
- TFR Capital bought 10 Bristol-Myers Squibb shares in Q2 2026, an estimated $574.
- Bristol-Myers Squibb made up 0.07% of TFR Capital's portfolio in Q2 2026, its #154 holding.
- TFR Capital first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 4 quarters since.
- TFR Capital's Bristol-Myers Squibb position peaked at $271K in Q1 2026.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on TFR Capital's 13F filing for Q2 2026, filed 6 Aug 2026.